Drugmakers are racing to secure health records and strike deals with technology companies, all to discover how medicines perform in the real world.
Data is at the heart of applicable genomics. As the volume and depth of genomic data grows, bioinformaticians are translating the data into interpretable patterns leading to new biological insight.
Researchers have developed a new method for sifting through genomic data in search of genetic variants that have helped populations adapt to their environments.
A USD $5 million technology prize aims to crack the origin of the genetic code. The Evolution 2.0 Prize was announced at Arizona State University in August 2017. The largest “origin of life” prize to date, it seeks to bridge the gap between chemistry, genomics and modern computing.
“I Would Like to See Widespread Reimbursement of Clinical Genomic Testing as Well as Screening” – Gavin Stone
Gavin Stone is an electronics engineer who joined Edico Genome in 2013 to lead corporate development and marketing for the DRAGEN™ Bio-IT Processor, the world’s first next-generation sequencing bioinformatics chip to massively speed up genomic medicine.
The technology used by Facebook, Google and Amazon to turn spoken language into text, recognize faces and target advertising could help doctors combat one of the deadliest killers in American hospitals.
DNAnexus launches new clinical trial solution that aims to streamline the incorporation of human genomic data into clinical trial designs.
As new technologies power the drive to achieve personalised health care, doctors may find it difficult to keep up with the pace of discovery. However, a recent collaboration between FDNA and the Manchester Centre for Genomic Medicine could soon change this.
Scientists have successfully mapped how genes are expressed differently in the brains of people with one of five major psychiatric disorders, providing a much needed deeper insight into how our genes influence our risk of developed mental illness, for the first time.
The GA4GH roadmap outlines the first set of standards and frameworks to be launched under GA4GH Connect—a new phase of the organization focused on aligning with the needs of the real-world genomic data sharing community.
SOPHiA GENETICS has unveiled the world’s first capture-based myeloid clinical solution to receive the CE-IVD mark. The standardized molecular diagnostic application represents a breakthrough in diagnostics for hematological diseases.
“I’d Like to See Our Understanding of at Least One More Disease Transformed by Genomics and Big Data” – Jeremy Grushcow
Combining over 15 years’ experience with pharma and life sciences businesses with a passion for participant-centric research, Jeremy Grushcow is CBO at Sequence Bio, where he saw a once-in-in a lifetime opportunity to change how we treat, prevent and understand disease.
Google’s DeepMind has potentially made the first significant application of Artificial Intelligence (A.I.) in healthcare, after developing AI to diagnose disease by analysing medical images.